AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source

Wed, 23rd Sep 2020 17:09

By Francesco Guarascio

BRUSSELS, Sept 23 (Reuters) - Brussels is close to wrapping
up preliminary talks with U.S. vaccine maker Novavax
for its potential COVID-19 shot, an EU source involved in the
negotiations said, as the bloc ramps up its push in the global
race to secure supplies.

The move is meant to expand to seven the portfolio of
vaccines the 27-country bloc, with a population of 450 million,
wants to secure. It would bring doses potentially available to
EU countries to more than 2 billion.

(Reporting by Francesco Guarascio; Editing by Josephine Mason
and Jan Harvey)

Related Shares

More News

Ireland steps further out of lockdown as some curbs lifted Monday

Ireland steps further out of lockdown as some curbs lifted Monday

Today 06:55

Sunday newspaper round-up: AstraZeneca, Virgin Atlantic, Boohoo

(Sharecast News) - AstraZeneca boss Pascal Soriot was last night at the centre of an extraordinary row among City investors over his multi-million-pound bonus. The French chief executive has been lauded for rolling out Astra's life-saving Covid vaccine at no profit, as well as fighting off predatory buyers and boosting the company's share price since he took charge in 2012. But Astra's major shareholders are understood to have been locked in heated talks for days after the drugs giant proposed to boost his bonus and performance-related share award by £2.3million to £12million. - Financial Mail on Sunday

9 May 21 20:21

IN BRIEF: EMA starts rolling review of Covid treatment by GSK and Vir

IN BRIEF: EMA starts rolling review of Covid treatment by GSK and Vir

7 May 21 14:08

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

7 May 21 09:49

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.